Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice
International Journal of Molecular Sciences · 13.04.2024 · 25 (8) · 4323
DOI: 10.3390/ijms25084323 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.04.2024. Verfasst von Luisa Agnello und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Biochemistry, Clinical Molecular Medicine, and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advan…. Hauptthemen laut MEDLINE: Biomarkers, Neurodegenerative Diseases. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neurodegenerative disorders (NDs) represent a group of different diseases characterized by the progressive degeneration and death of the nervous system’s cells. The diagnosis is challenging, especially in the early stages, due to no specific clinical signs and symptoms. In this context, laboratory medicine could support clinicians in detecting and differentiating NDs. Indeed, biomarkers could indicate the pathological mechanisms underpinning NDs. The ideal biofluid for detecting the biomarkers of NDs is cerebrospinal fluid (CSF), which has limitations, hampering its widespread use in clinical practice. However, intensive efforts are underway to introduce high-sensitivity analytical methods to detect ND biomarkers in alternative nonivasive biofluid, such as blood or saliva. This study presents an overview of the ND molecular biomarkers currently used in clinical practice. For some diseases, such as Alzheimer’s disease or multiple sclerosis, biomarkers are well established and recommended by guidelines. However, for most NDs, intensive research is ongoing to identify reliable and specific biomarkers, and no consensus has yet been achieved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Biochemistry, Clinical Molecular Medicine, and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy.
- Department of Laboratory Medicine, University Hospital "P. Giaccone", 90127 Palermo, Italy.
- Internal Medicine and Medical Specialties "G. D'Alessandro", Department of Health Promotion, Maternal and Infant Care, University of Palermo, 90127 Palermo, Italy.
ORCID-Profile: Marcello Ciaccio
Zitieren
APA
Agnello, L., Gambino, C. M., Ciaccio, A. M., Masucci, A., Vassallo, R., Tamburello, M., Scazzone, C., Lo Sasso, B., & Ciaccio, M. (2024). Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice. International Journal of Molecular Sciences, 25(8), 4323. https://doi.org/10.3390/ijms25084323
Vancouver
Agnello L, Gambino CM, Ciaccio AM, Masucci A, Vassallo R, Tamburello M, et al. Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice. International Journal of Molecular Sciences. 2024;25(8):4323. doi:10.3390/ijms25084323
BibTeX
@article{Agnello2024,
author = {Agnello, Luisa and Gambino, Caterina Maria and Ciaccio, Anna Maria and Masucci, Anna and Vassallo, Roberta and Tamburello, Martina and Scazzone, Concetta and Lo Sasso, Bruna and Ciaccio, Marcello},
title = {Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {8},
pages = {4323},
doi = {10.3390/ijms25084323}
}
EUVIMED